Patent Yard Sign in
Expired European patentEurope

Repressed trans-activator system for characterization of protein-protein interactions

EP 1012265 B1 · Applicant: Interomex Biopharmaceuticals Inc.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Google PatentsEPO PDF

Why it's free to use

  • Filed September 8, 1998 and granted August 3, 2005. A European patent lasts at most 20 years from filing, so its term ended September 8, 2018.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by March 8, 2024.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledSeptember 8, 1998
PublishedJune 28, 2000
GrantedAugust 3, 2005
Term endedSeptember 8, 2018
Application numberEP 98942417
Classification (CPC)C12Q1/6897 +2 more

Timeline

Timeline From EPO dates

1999200120032005200720092011201320152017Application filedSep 8, 1998PublishedJune 28, 2000Patent grantedAug 3, 2005Term endedSep 8, 2018

Sources & verification

Official EPO records

Full published documentClaims, description and drawings as a PDF.EPOEuropean Patent RegisterProcedure, status, file inspection and legal events.EPOLinked open EP data recordThe bibliographic record this page is built from.EPO

Cross-check elsewhere

Google PatentsFull text, worldwide family, citing patents and legal events.patents.google.comEspacenetNational family members and their legal status.European Patent Office

Everything on this page comes from the EPO record linked above. EPO data used under CC BY 4.0.